210 related articles for article (PubMed ID: 36801923)
21. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.
Murtaza I; Saleem M; Adhami VM; Hafeez BB; Mukhtar H
Cancer Res; 2009 Feb; 69(3):1156-65. PubMed ID: 19176377
[TBL] [Abstract][Full Text] [Related]
22. IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.
Briggs LC; Chan AWE; Davis CA; Whitelock N; Hotiana HA; Baratchian M; Bagnéris C; Selwood DL; Collins MK; Barrett TE
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931678
[TBL] [Abstract][Full Text] [Related]
23. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis.
Poondla N; Chandrasekaran AP; Heese K; Kim KS; Ramakrishna S
Biochem Biophys Res Commun; 2019 Apr; 512(1):60-65. PubMed ID: 30862357
[TBL] [Abstract][Full Text] [Related]
25. cFLIP
Davidovich P; Higgins CA; Najda Z; Longley DB; Martin SJ
Cell Rep; 2023 Dec; 42(12):113476. PubMed ID: 37988267
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis.
Braun FK; Mathur R; Sehgal L; Wilkie-Grantham R; Chandra J; Berkova Z; Samaniego F
PLoS One; 2015; 10(3):e0117994. PubMed ID: 25738497
[TBL] [Abstract][Full Text] [Related]
27. MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression.
Matte I; Lane D; Boivin M; Rancourt C; Piché A
BMC Cancer; 2014 Apr; 14():234. PubMed ID: 24690311
[TBL] [Abstract][Full Text] [Related]
28. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.
Yerbes R; López-Rivas A
Invest New Drugs; 2012 Apr; 30(2):541-7. PubMed ID: 21107885
[TBL] [Abstract][Full Text] [Related]
29. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
30. KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome.
Ehrlich ES; Chmura JC; Smith JC; Kalu NN; Hayward GS
PLoS One; 2014; 9(3):e91359. PubMed ID: 24614587
[TBL] [Abstract][Full Text] [Related]
31. Caspase-10 Negatively Regulates Caspase-8-Mediated Cell Death, Switching the Response to CD95L in Favor of NF-κB Activation and Cell Survival.
Horn S; Hughes MA; Schilling R; Sticht C; Tenev T; Ploesser M; Meier P; Sprick MR; MacFarlane M; Leverkus M
Cell Rep; 2017 Apr; 19(4):785-797. PubMed ID: 28445729
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
33. In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.
Moujalled DM; Cook WD; Lluis JM; Khan NR; Ahmed AU; Callus BA; Vaux DL
Cell Death Differ; 2012 May; 19(5):808-15. PubMed ID: 22095280
[TBL] [Abstract][Full Text] [Related]
34. SUMO Modification of Histone Demethylase KDM4A in Kaposi's Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Yeh WW; Chen YQ; Yang WS; Hong YC; Kao S; Liu TT; Chen TW; Chang L; Chang PC
J Virol; 2022 Aug; 96(16):e0075522. PubMed ID: 35914074
[TBL] [Abstract][Full Text] [Related]
35. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H
Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
[TBL] [Abstract][Full Text] [Related]
37. Balance between short and long isoforms of cFLIP regulates Fas-mediated apoptosis in vivo.
Ram DR; Ilyukha V; Volkova T; Buzdin A; Tai A; Smirnova I; Poltorak A
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1606-11. PubMed ID: 26798068
[TBL] [Abstract][Full Text] [Related]
38. KSHV vFLIP is essential for the survival of infected lymphoma cells.
Guasparri I; Keller SA; Cesarman E
J Exp Med; 2004 Apr; 199(7):993-1003. PubMed ID: 15067035
[TBL] [Abstract][Full Text] [Related]
39. Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas.
Heijink DM; Kleibeuker JH; Jalving M; Boersma-van Ek W; Koornstra JJ; Wesseling J; de Jong S
Cell Oncol; 2007; 29(5):409-19. PubMed ID: 17726263
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis.
Clarke P; Tyler KL
Apoptosis; 2007 Jan; 12(1):211-23. PubMed ID: 17136319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
